Related Experiment Video
Updated: Oct 9, 2025

08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
694
Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply
Mikhail N Kosiborod1, Russell Esterline2, Jan Oscarsson3
1Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO 64111, USA; Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
The Lancet. Diabetes & Endocrinology
|December 18, 2021
Abstract
No abstract available in PubMed .

